European Federation of Pharmaceutical Industries and Associations

At a glance

Disclosed meetings

Newest first, showing the most recent 60 of 150. EC = European Commission, EP = Member of the European Parliament.

• 2026-05-22ECPatrick Child · Deputy Director-General
  Extended Producer Responsibility under the recast Urban Wastewater Treatment Directivesource ↗
• 2026-05-20EPKALJURAND Marina
  Digital Omnibussource ↗
• 2026-05-07EPVERYGA Aurelijus
  Hosting the Conference "Promoting Early Detection for Better Cardiovascular Outcomes: Towards Comprehensive Health Check Programmes Across Europe"source ↗
• 2026-05-04ECMartin Seychell · Deputy Director-General
  Exchange of views on the EU global health approach, local manufacturing agenda and role of the EU pharmaceutical industry.source ↗
• 2026-05-04EPBOSSE Stine
  Biotech Act expert briefing sessionsource ↗
• 2026-04-28EPVERYGA Aurelijus
  Cardiovascular Health Policy and Innovation in the EUsource ↗
• 2026-04-21ECLaszlo Kristoffy · Cabinet of Commissioner Olivér Várhelyi
  Current pharma affairssource ↗
• 2026-04-16ECJana Dabbelt · Cabinet of Commissioner Olivér Várhelyi
  Health industry roundtablesource ↗
• 2026-04-16EPWÖLKEN Tiemo
  Biotech Actsource ↗
• 2026-04-16EPTER LAAK Ingeborg
  Biotech Actsource ↗
• 2026-04-14EPWÖLKEN Tiemo
  Urban Waste Water Directive - Resolutionsource ↗
• 2026-04-13EPMCNAMARA Michael
  Digital Omnibussource ↗
• 2026-03-30EPNIEBLER Angelika
  EU Health Policysource ↗
• 2026-03-26ECNils Behrndt · Deputy Secretary-General
  Current context of pharmaceutical production in the EU and major challengessource ↗
• 2026-03-26EPCICCIOLI Carlo
  Biotech actsource ↗
• 2026-03-25ECEstelle Goeger · Cabinet of Executive Vice-President Stéphane Séjourné
  International context of the pharmaceutical industrysource ↗
• 2026-03-24EPWEBER Manfred
  Politischer Austauschsource ↗
• 2026-03-24EPANDRIUKAITIS Vytenis Povilas
  Biotech Actsource ↗
• 2026-03-24EPBEKE Wouter
  Biotech Act Isource ↗
• 2026-03-19ECMarc Lemaitre · Director-General
  Next generation of European public-private partnerships under FP10 / Horizon Europesource ↗
• 2026-03-19EPWÖLKEN Tiemo
  MDR/IVDRsource ↗
• 2026-03-16EPVASILE-VOICULESCU Vlad
  EBCP reportsource ↗
• 2026-03-05EPGLÜCK Andreas
  Health Policysource ↗
• 2026-02-25ECMarco Chirullo · Head of Unit
  Exchange of views on EU cooperation with China and Japan in the field of biopharmaceutical innovation and supply chain resilience.source ↗
• 2026-02-25ECLucian Cernat · Head of Unit
  Mutual Recognition Agreements (MRAs) for pharmaceutical products with reference to the UK and Türkiyesource ↗
• 2026-02-25EPWARBORN Jörgen
  EU-US tradesource ↗
• 2026-02-17ECOlivér Várhelyi · Cabinet of Commissioner Olivér Várhelyi
  Biotech Act, Pharma package, CMAsource ↗
• 2026-02-16EPNEGRESCU Victor
  Exchange on the cardiovascular strategysource ↗
• 2026-02-11ECJana Dabbelt · Cabinet of Commissioner Olivér Várhelyi
  Environmental legislationsource ↗
• 2026-02-11ECMaya Matthews · Head of Unit
  Exchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs)source ↗
• 2026-02-11EPWECHSLER Andrea
  EU Industry Policysource ↗
• 2026-01-27EPPOLFJÄRD Jessica
  Health policysource ↗
• 2026-01-27EPANDRIUKAITIS Vytenis Povilas
  Exchange of viewssource ↗
• 2026-01-21ECEric Mamer · Director-General
  General discussion on DG ENV prioritiessource ↗
• 2026-01-21EPPIETIKÄINEN Sirpa
  Cardio vascular deseases strategysource ↗
• 2026-01-20EPMANIATIS Yannis
  Introductory Meetingsource ↗
• 2026-01-15ECCarmen Laplaza Santos · Head of Unit
  Exchange of views with private members of the Innovative Health Initiative Joint Undertaking (IHI-JU).source ↗
• 2026-01-15ECMaria Pilar Aguar Fernandez · Director
  Exchange of views with private members of the Innovative Health Initiative Joint Undertaking (IHI-JU).source ↗
• 2026-01-15EPCIFROVÁ OSTRIHOŇOVÁ Veronika
  cardiovascular healthsource ↗
• 2025-12-11ECCarmen Laplaza Santos · Head of Unit
  Assessment of micropollutants in wastewatersource ↗
• 2025-12-03ECOlivér Várhelyi · Cabinet of Commissioner Olivér Várhelyi
  Future of European pharmaceuticals sectorsource ↗
• 2025-12-02ECEkaterina Zaharieva · Cabinet of Commissioner Ekaterina Zaharieva
  Life sciencessource ↗
• 2025-12-02EPGONZÁLEZ CASARES Nicolás
  Pharmaceutical legislationsource ↗
• 2025-12-02EPWÖLKEN Tiemo
  Pharma Packagesource ↗
• 2025-11-26EPMONTSERRAT Dolors
  Review of the EU General Pharmaceutical Legislationsource ↗
• 2025-11-18EPANDRIUKAITIS Vytenis Povilas
  Exchange of viewssource ↗
• 2025-11-17EPCAVAZZINI Anna
  EU-US relationsource ↗
• 2025-11-13EPHEINÄLUOMA Eero
  Critical Medicines Actsource ↗
• 2025-11-13EPNIEBLER Angelika
  EU Pharmaceutical Policysource ↗
• 2025-11-12EPJERKOVIĆ Romana
  Cardiovascular Healthsource ↗
• 2025-11-12EPWALSMANN Marion
  CMAsource ↗
• 2025-11-04ECKilian Gross · Head of Unit
  Exchange of views on the AI Act and how it applies to research and development activitiessource ↗
• 2025-10-28ECDorota Denning · Cabinet of Commissioner Valdis Dombrovskis
  Roundtable on Simplification for Pharmaceutical Innovationsource ↗
• 2025-10-27EPTER LAAK Ingeborg
  CMA & Biotech Actsource ↗
• 2025-10-24EPJARUBAS Adam
  EU pharmaceutical policiessource ↗
• 2025-10-22ECMaya Matthews · Head of Unit
  Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.source ↗
• 2025-10-22EPVERYGA Aurelijus
  Discussion on the Critical Medicines Actsource ↗
• 2025-10-22EPGONZÁLEZ CASARES Nicolás
  Critical Medicines Actsource ↗
• 2025-10-21EPNEVADO DEL CAMPO Elena
  Critical Medicines Actsource ↗
• 2025-10-17ECAgnes Mathieu-Mendes · Head of Unit
  Leem & Efpia | Request for a meeting - France's medicines shortages regulatory framework & policiessource ↗

Lobbying in these areas

Frequently asked